27.02.2026.
Original article
Pharmacology
In the next Issue
Molecular docking analysis of thymoquinone as a potential inhibitor of C-reactive protein and transforming growth factor β (TGF-β): an in-silico study for myocardial infarction therapeutics
Abstract Background: Myocardial infarction (MI) is a cardiovascular disease that is the leading cause of death at all ages. Inflammation and oxidation processes constitute the basic pathophysiology of MI development. C-reactive protein (CRP) and transforming growth factor β (TGF-β) are markers that are often used to evaluate the level of...
By Muhammad Saugi Abduh, Ahmad Umar Alfaruq, Muh Adytia Prasada, Dimas Nabih